Clinical trial
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
NCT00254189 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00254189 |
|---|---|
| Title | Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation |
| Official title | A Single Center, Open-Label Study to Evaluate the Effects on Ovulation of Levonorgestrel 90mg and Ethinyl Estradiol 20mg in a Daily, Continuous, Oral Regimen. |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovulation |
| Intervention type | Drug |
| Interventions | Levonorgestrel, Ethinyl Estradiol |
| Enrollment | 60 |
| Start date | Dec 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Nov 15, 2005 |
| Last update posted | May 19, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: